Technology | February 01, 2010

FDA Clears All-in-One Introducer Device for Safer Vascular Access


February 1, 2010 – The FDA granted market clearance for the PICC WAND introducer catheter, which enables clinicians to insert a peelable sheath for PICC or midline catheter placement using the new Accelerated Seldinger Technique (AST), for faster vascular access. The device is an all-in-one safety introducer that addresses the over-wire vascular access market by providing faster, safer and simpler vascular access. The PICC WAND combines all components of the older, Modified Seldinger Technique (MST) – the needle, guide wire, dilator and sheath – into one device that also protects against accidental needle sticks. Additionally, its “Fast-flash” feature provides early detection of vessel entry. Access Scientific partnered with Teleflex Medical to introduce the PICC WAND. It is designed to reduce the risk of accidental needle sticks, bleeding, contamination, guide wire embolism, and loss of cannulation. Air embolism is among the patient risks of MST that are reduced by the WAND and its Accelerated Seldinger Technique. Beginning in October 2008, the Centers for Medicare Medicaid Services (CMS) ceased reimbursing healthcare institutions for air embolism, which CMS considers preventable. The average cost to treat this complication, which can be fatal, is estimated at $66,000 per case. "The WAND facilitates PICC placement by enabling me to quickly and safely gain venous access," said Erin Capo, P.A. a vascular access specialist in the New York City metropolitan area. "The innovative design minimizes blood loss, decreases procedure time, optimizes operator safety and increases patient comfort. I have seen these benefits first-hand, and I am convinced that many other vascular specialists will adopt this technology." The device is designed to be used primarily by vascular nurse specialists for insertion of PICCs. The Seldinger technique was developed in 1953 to reduce complications associated with the introduction of catheters and other medical devices into blood vessels and hollow organs. Because there have been few significant improvements to the technique since it was invented, what is now known as the Modified Seldinger Technique (MST) still carries risks for patients and clinicians. For more information: www.The-Wand.com


Related Content

Feature | Catheters | By Allied Market Research

According to a new report from Allied Market Research, the global catheters market was valued at $22.7 billion in 2021 ...

Home June 09, 2022
Home
News | Catheters

May 10, 2022 — The MIVI Neuroscience Q Aspiration Catheter incorporates a novel pusher wire design on its proximal end ...

Home May 10, 2022
Home
News | Catheters
April 21, 2022 – MIVI Neuroscience, Inc., innovator of the next generation of neurointerventional medical devices, today ...
Home April 21, 2022
Home
News | Catheters

February 9, 2022 — Innovative Health, LLC, a specialty cardiology reprocessor, has announced that the company has ...

Home February 09, 2022
Home
News | Catheters

October 23, 2019 — BioCardia announced the U.S. commercial availability of its Avance Bi-Directional Steerable ...

Home October 23, 2019
Home
Technology | Catheters

August 23, 2019 — Cook Medical recently released the second generation of the 2.6 Fr CXI Support Catheter with platinum ...

Home August 23, 2019
Home
Technology | Catheters

May 16, 2019 — BioCardia Inc. announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Avance steerable ...

Home May 16, 2019
Home
News | Catheters

February 21, 2019 — Navitian, the new coronary microcatheter from iVascular, recently received CE mark approval. The ...

Home February 21, 2019
Home
News | Catheters

January 31, 2019 — Cardiovascular Systems Inc. announced that the first patients in the United States were treated using ...

Home January 31, 2019
Home
News | Catheters

December 18, 2018 — Merit Medical Systems Inc. announced that it has acquired substantially all of the assets of ...

Home December 18, 2018
Home
Subscribe Now